News About: R&D
Investment efficiency of new drug R&D enhanced by out-sourcing
The commercialization of the first domestic new drug strongly motivated local pharmaceutical industry to seek enhancement of efficiency in new drug R&D investment by means of utilizing the third party resource in thei...
Foreigner's drug community seeks government special privilege on new drugs.
The foreign pharmaceutical corporations made a strategic approach to our government through an international diplomatic channel and American PMA for the future new drugs to get the price approval at a higher level tha...
Domestic and foreign drug firms on patent dispute.
As domestic firms are developing new drugs that could be manufactured by their patented process developed by their own research and technology resulting from the R&D progress through long time investment for their res...
Insurance price determination standards for new drugs under review.
The MOHW plans to make a Task Force for overall review of the new standards for insurance drug price determination that should be more reasonable and objective in consideration with characteristics of drugs and their ...
Whanin developed alcohol detoxicated drug for world 2nd time.
Whanin pharmaceutical company developed a manufacture of Acamprosate, an alcohol detoxicated drug under a joint research with Estech, a domestic venture company producing pharmaceutical bulk products after obtaining t...
Insurance pricing on new drugs specially privileged
The foreign multinational drug companies and local drug industries shared with common goals for the future insurance reimbursement price of new drugs to get some privileges in process of the government price determina...
Dongwha's DW166HC likely to be No. 2 new drugs in Korea.
SK pharmaceutical obtained the manufacturing licence of a platinum complex preparation as a new drug with passing through the clinical phase II studies only, which was exceptional for an anticancer drug while provisio...
Sunpla expected yearly to yeild 10 billion won of sales
As reported earlier SK Chemical and SK Pharmaceutical has developed an anti-cancer drug, a platinum complex, under the brand of Sunpla by about 8.1 billion won of investment during the past 10 years, which becomes the...
Domestic new drug No. 1, Sunpla inj. approved
The KFDA approved Sunpla inj., a platinum chelate complex anticancer drug, as the first new drug originated from Korea on July 13, which was developed by SK Pharmaceutical (President: Cho Min-ho) at 8.1 billion won of...
21 new drugs under clinical research.
Along with the first introduction of domestically developed new drug many interesting attentions are paid to the 21 candidates of new drugs in future, which are still under the clinical research stage and 2 ...
Which are outstanding tetravalent vaccines even for the young?
Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer
Who will be the next Pharmaceutical Safety Bureau Director?
Celltrion completes clinical trials for Remsima SC for European approval
Sales listed pharmas made in the first half of the year
April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
30 | 31 | 1 | 2 | 3 | 4 | 5 |
6 | 7 | 8 | 9 | 10 | 11 | 12 |
13 | 14 | 15 | 16 | 17 | 18 | 19 |
20 | 21 | 22 | 23 | 24 | 25 | 26 |
27 | 28 | 29 | 30 | 1 | 2 | 3 |
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
